352 related articles for article (PubMed ID: 16375251)
1. Mass spectrometry and HPLC for carbohydrate analysis.
Siemiiatkoski J; Lyubarskaya Y
Dev Biol (Basel); 2005; 122():69-74. PubMed ID: 16375251
[TBL] [Abstract][Full Text] [Related]
2. A study of immunoglobulin G glycosylation in monoclonal and polyclonal species by electrospray and matrix-assisted laser desorption/ionization mass spectrometry.
Saba JA; Kunkel JP; Jan DC; Ens WE; Standing KG; Butler M; Jamieson JC; Perreault H
Anal Biochem; 2002 Jun; 305(1):16-31. PubMed ID: 12018942
[TBL] [Abstract][Full Text] [Related]
3. Mass spectrometry and HPLC with fluorescent detection-based orthogonal approaches to characterize N-linked oligosaccharides of recombinant monoclonal antibodies.
Lucka AW; Kilgore BR; Patel R; Andrien BA; Dhume ST
Methods Mol Biol; 2008; 446():347-61. PubMed ID: 18373269
[TBL] [Abstract][Full Text] [Related]
4. Immobilisation of antibodies in gels allows the improved release and identification of glycans.
Charlwood J; Skehel JM; Camilleri P
Proteomics; 2001 Feb; 1(2):275-84. PubMed ID: 11680874
[TBL] [Abstract][Full Text] [Related]
5. Analysis of N-glycans from recombinant immunoglobulin G by on-line reversed-phase high-performance liquid chromatography/mass spectrometry.
Chen X; Flynn GC
Anal Biochem; 2007 Nov; 370(2):147-61. PubMed ID: 17880905
[TBL] [Abstract][Full Text] [Related]
6. Production and molecular characterization of clinical phase i anti-melanoma mouse IgG3 monoclonal antibody R24.
Kemminer SE; Conradt HS; Nimtz M; Sagi D; Peter-Katalinić J; Diekmann O; Drmić I; Müthing J
Biotechnol Prog; 2001; 17(5):809-21. PubMed ID: 11587568
[TBL] [Abstract][Full Text] [Related]
7. N-glycans of recombinant human acid alpha-glucosidase expressed in the milk of transgenic rabbits.
Jongen SP; Gerwig GJ; Leeflang BR; Koles K; Mannesse ML; van Berkel PH; Pieper FR; Kroos MA; Reuser AJ; Zhou Q; Jin X; Zhang K; Edmunds T; Kamerling JP
Glycobiology; 2007 Jun; 17(6):600-19. PubMed ID: 17293352
[TBL] [Abstract][Full Text] [Related]
8. Characterization of IgG N-glycans employing a microfluidic chip that integrates glycan cleavage, sample purification, LC separation, and MS detection.
Bynum MA; Yin H; Felts K; Lee YM; Monell CR; Killeen K
Anal Chem; 2009 Nov; 81(21):8818-25. PubMed ID: 19807107
[TBL] [Abstract][Full Text] [Related]
9. A comparison of three techniques for quantitative carbohydrate analysis used in characterization of therapeutic antibodies.
Siemiatkoski J; Lyubarskaya Y; Houde D; Tep S; Mhatre R
Carbohydr Res; 2006 Feb; 341(3):410-9. PubMed ID: 16378604
[TBL] [Abstract][Full Text] [Related]
10. In vitro galactosylation of human IgG at 1 kg scale using recombinant galactosyltransferase.
Warnock D; Bai X; Autote K; Gonzales J; Kinealy K; Yan B; Qian J; Stevenson T; Zopf D; Bayer RJ
Biotechnol Bioeng; 2005 Dec; 92(7):831-42. PubMed ID: 16187338
[TBL] [Abstract][Full Text] [Related]
11. Comparison of methods for the analysis of therapeutic immunoglobulin G Fc-glycosylation profiles-Part 2: Mass spectrometric methods.
Reusch D; Haberger M; Falck D; Peter B; Maier B; Gassner J; Hook M; Wagner K; Bonnington L; Bulau P; Wuhrer M
MAbs; 2015; 7(4):732-42. PubMed ID: 25996192
[TBL] [Abstract][Full Text] [Related]
12. Characterization and direct glycoform profiling of a hybrid plasminogen activator by matrix-assisted laser desorption and electrospray mass spectrometry: correlation with high-performance liquid chromatographic and nuclear magnetic resonance analyses of the released glycans.
Müller D; Domon B; Karas M; van Oostrum J; Richter WJ
Biol Mass Spectrom; 1994 Jun; 23(6):330-8. PubMed ID: 8038226
[TBL] [Abstract][Full Text] [Related]
13. Variations in oligosaccharide-protein interactions in immunoglobulin G determine the site-specific glycosylation profiles and modulate the dynamic motion of the Fc oligosaccharides.
Wormald MR; Rudd PM; Harvey DJ; Chang SC; Scragg IG; Dwek RA
Biochemistry; 1997 Feb; 36(6):1370-80. PubMed ID: 9063885
[TBL] [Abstract][Full Text] [Related]
14. IgG glycosylation analysis.
Huhn C; Selman MH; Ruhaak LR; Deelder AM; Wuhrer M
Proteomics; 2009 Feb; 9(4):882-913. PubMed ID: 19212958
[TBL] [Abstract][Full Text] [Related]
15. Proteomic analysis of glycosylation: structural determination of N- and O-linked glycans by mass spectrometry.
Harvey DJ
Expert Rev Proteomics; 2005 Jan; 2(1):87-101. PubMed ID: 15966855
[TBL] [Abstract][Full Text] [Related]
16. Analysis of protein glycosylation by mass spectrometry.
Morelle W; Michalski JC
Nat Protoc; 2007; 2(7):1585-602. PubMed ID: 17585300
[TBL] [Abstract][Full Text] [Related]
17. Glycan variability on a recombinant IgG antibody transiently produced in HEK-293E cells.
Nallet S; Fornelli L; Schmitt S; Parra J; Baldi L; Tsybin YO; Wurm FM
N Biotechnol; 2012 May; 29(4):471-6. PubMed ID: 22401955
[TBL] [Abstract][Full Text] [Related]
18. High-throughput immunoglobulin G N-glycan characterization using rapid resolution reverse-phase chromatography tandem mass spectrometry.
Prater BD; Connelly HM; Qin Q; Cockrill SL
Anal Biochem; 2009 Feb; 385(1):69-79. PubMed ID: 19000897
[TBL] [Abstract][Full Text] [Related]
19. Analysis of nonhuman N-glycans as the minor constituents in recombinant monoclonal antibody pharmaceuticals.
Maeda E; Kita S; Kinoshita M; Urakami K; Hayakawa T; Kakehi K
Anal Chem; 2012 Mar; 84(5):2373-9. PubMed ID: 22394092
[TBL] [Abstract][Full Text] [Related]
20. Assessing Fc glycan heterogeneity of therapeutic recombinant monoclonal antibodies using NP-HPLC.
Raju TS
Methods Mol Biol; 2013; 988():169-80. PubMed ID: 23475719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
